These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7588225)
1. Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis. Stannard B; Blakesley V; Kato H; Roberts CT; LeRoith D Endocrinology; 1995 Nov; 136(11):4918-24. PubMed ID: 7588225 [TBL] [Abstract][Full Text] [Related]
2. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor. Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783 [TBL] [Abstract][Full Text] [Related]
3. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals. Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243 [TBL] [Abstract][Full Text] [Related]
5. The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis. Hernández-Sánchez C; Blakesley V; Kalebic T; Helman L; LeRoith D J Biol Chem; 1995 Dec; 270(49):29176-81. PubMed ID: 7493944 [TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis. Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048 [TBL] [Abstract][Full Text] [Related]
7. Structure-function of the human insulin-like growth factor-I receptor: a discordance of somatotroph internalization and signaling. Yamasaki H; Prager D; Melmed S Mol Endocrinol; 1993 May; 7(5):681-5. PubMed ID: 8316251 [TBL] [Abstract][Full Text] [Related]
8. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. Grønborg M; Wulff BS; Rasmussen JS; Kjeldsen T; Gammeltoft S J Biol Chem; 1993 Nov; 268(31):23435-40. PubMed ID: 7693688 [TBL] [Abstract][Full Text] [Related]
9. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation. Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864 [TBL] [Abstract][Full Text] [Related]
10. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Miura M; Li S; Baserga R Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637 [TBL] [Abstract][Full Text] [Related]
11. Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function. Blakesley VA; Kato H; Roberts CT; LeRoith D J Biol Chem; 1995 Feb; 270(6):2764-9. PubMed ID: 7852347 [TBL] [Abstract][Full Text] [Related]
12. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine. Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780 [TBL] [Abstract][Full Text] [Related]
13. NPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling. Hsu D; Knudson PE; Zapf A; Rolband GC; Olefsky JM Endocrinology; 1994 Feb; 134(2):744-50. PubMed ID: 8299569 [TBL] [Abstract][Full Text] [Related]
14. The tyrosine residue at 1250 of the insulin-like growth factor I receptor is required for ligand-mediated internalization. Miura M; Baserga R Biochem Biophys Res Commun; 1997 Oct; 239(1):182-5. PubMed ID: 9345292 [TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825 [TBL] [Abstract][Full Text] [Related]
16. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166 [TBL] [Abstract][Full Text] [Related]
18. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical biological effects of overexpressed insulin-like growth factor-1 receptors in Chinese hamster ovary cells. Kato H; Faria TN; Stannard B; Levy-Toledano R; Taylor SI; Roberts CT; LeRoith D J Cell Physiol; 1993 Jul; 156(1):145-52. PubMed ID: 7686165 [TBL] [Abstract][Full Text] [Related]
20. Ethanol inhibits insulin-like growth factor-1-mediated signalling and proliferation of C6 rat glioblastoma cells. Resnicoff M; Rubini M; Baserga R; Rubin R Lab Invest; 1994 Nov; 71(5):657-62. PubMed ID: 7526037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]